PET-CT Beyond FDG A Quick Guide to Image Interpretation

Although [18F]fluorodeoxyglucose (FDG) generally shows an excellent performance as a cancer-imaging agent when using PET-CT, there are some settings in which other radiopharmaceuticals offer advantages. Such non-FDG tracers are now gaining widespread acceptance not only in research but also in clini...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Fanti, Stefano (Επιμελητής έκδοσης), Farsad, Mohsen (Επιμελητής έκδοσης), Mansi, Luigi (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2010.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03110nam a22004815i 4500
001 978-3-540-93909-2
003 DE-He213
005 20151125191929.0
007 cr nn 008mamaa
008 100508s2010 gw | s |||| 0|eng d
020 |a 9783540939092  |9 978-3-540-93909-2 
024 7 |a 10.1007/978-3-540-93909-2  |2 doi 
040 |d GrThAP 
050 4 |a R895-920 
072 7 |a MMN  |2 bicssc 
072 7 |a MED080000  |2 bisacsh 
082 0 4 |a 616.07548  |2 23 
245 1 0 |a PET-CT Beyond FDG A Quick Guide to Image Interpretation  |h [electronic resource] /  |c edited by Stefano Fanti, Mohsen Farsad, Luigi Mansi. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint: Springer,  |c 2010. 
300 |a X, 243 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Importance of Radiotracers Other than FDG in Oncology -- Considerations About PET Isotopes -- Choline PET-CT -- Methionine PET-CT -- Fluoride PET-CT -- Tyrosine PET-CT -- Somatostatin Receptor PET-CT -- Acetate PET-CT -- Thymidine PET-CT -- Dopa PET-CT -- Imaging of Hypoxia with PET-CT -- Angiogenesis PET Using Radiolabeled RGD Peptides -- Hormonal Receptors PET-CT -- HTP PET-CT. 
520 |a Although [18F]fluorodeoxyglucose (FDG) generally shows an excellent performance as a cancer-imaging agent when using PET-CT, there are some settings in which other radiopharmaceuticals offer advantages. Such non-FDG tracers are now gaining widespread acceptance not only in research but also in clinical practice, with the acquisition of promising results in the management of various cancers. This atlas, including about 500 high-quality images, is a user-friendly guide to PET-CT imaging beyond FDG. A wide range of tracers is covered, such as 18F- and 11C-choline, 11C-methionine, 18F-ethyl-L-tyrosine, 68Ga-DOTA-NOC, 11C-acetate, 11C-thymidine, and 18F-DOPA. Throughout, the emphasis is on image interpretation, with guidance on the recognition of normal, benign, and malignant uptake and clear instruction on learning points and pitfalls. This book is a companion to the editors’ recently published Atlas of PET-CT, which focuses exclusively on the use of FDG. It is designed to serve as a reference text for both nuclear physicians and radiologists, and will also be of great benefit to radiographers, technologists, and nuclear medicine and radiology residents. 
650 0 |a Medicine. 
650 0 |a Radiology. 
650 0 |a Nuclear medicine. 
650 0 |a Oncology. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Nuclear Medicine. 
650 2 4 |a Imaging / Radiology. 
650 2 4 |a Oncology. 
700 1 |a Fanti, Stefano.  |e editor. 
700 1 |a Farsad, Mohsen.  |e editor. 
700 1 |a Mansi, Luigi.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783540939085 
856 4 0 |u http://dx.doi.org/10.1007/978-3-540-93909-2  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)